Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with …

D van der Heijde, JCC Wei, M Dougados, P Mease… - The Lancet, 2018 - thelancet.com
Background Biological disease-modifying anti-rheumatic drugs (bDMARDs) are
recommended for radiographic axial spondyloarthritis, otherwise known as ankylosing …

[HTML][HTML] Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

M Dougados, D van der Heijde, YC Chen… - Annals of the …, 2017 - ard.bmj.com
Background Baricitinib is an oral, reversible, selective Janus kinase 1 and 2 inhibitor.
Methods In this phase III, double-blind 24-week study, 684 biologic disease-modifying …

Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis

A Deodhar, LS Gensler, J Sieper, M Clark… - Arthritis & …, 2019 - Wiley Online Library
Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐
controlled studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included …

[HTML][HTML] Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy

CC Lin, TL Cheng, WH Tsai, HJ Tsai, KH Hu… - Scientific reports, 2012 - nature.com
To investigate whether altered energy metabolism induces the Warburg effect and results in
tumor malignancy, the respiratory enzyme citrate synthase (CS) was examined, silenced …

[HTML][HTML] Recommendations for psoriatic arthritis management: a joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for …

TF Tsai, TY Hsieh, CC Chi, CT Chou, LF Hsieh… - Journal of the Formosan …, 2021 - Elsevier
In Taiwan, the incidence and prevalence of psoriatic arthritis (PsA) have risen significantly in
recent years. Moreover, data from the Taiwan National Health Insurance Research …

Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case–control …

CY Hsu, MS Lin, YJ Su, TT Cheng, YS Lin… - …, 2017 - academic.oup.com
Objectives. Immunosuppressive therapy is necessary to alter the natural course of SLE.
However, immunosuppressant-related cancer risk is a major concern. The aim of this study …

Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences

HM Lai, CJ Chen, BYJ Su, YC Chen, SF Yu… - …, 2012 - academic.oup.com
Objective. To explore the causal relationship between gout and Type 2 diabetes based on
genetic evidence and national outpatient database. Methods. Twenty male gout patients …

The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis

JF Chen, CY Hsu, SF Yu, CH Ko, WC Chiu… - …, 2020 - academic.oup.com
Objectives To investigate changes in BMD in RA patients receiving 3-year
biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) or …

[HTML][HTML] Effects of diet control and telemedicine-based resistance exercise intervention on patients with obesity and knee osteoarthritis: a randomized control trial

YI Hsu, YC Chen, CL Lee, NJ Chang - International Journal of …, 2021 - mdpi.com
This study investigated the effects of home-based nutritional and telemedicine-based
resistance exercise interventions on improving body composition, blood biochemistry, and …

Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus

CY Hsu, YS Lin, TT Cheng, YJ Syu, MS Lin… - …, 2018 - academic.oup.com
Objectives HCQ, which is known to decrease SLE activity, may have a protective effect on
survival, but this has not been proven in Asia. This study aimed to determine whether HCQ …